Characteristics of lung cancers harboring NRAS mutations.Ohashi K, Sequist LV, Arcila ME, Lovly CM, Chen X, Rudin CM, Moran T, Camidge DR, Vnencak-Jones CL, Berry L, Pan Y, Sasaki H, Engelman JA, Garon EB, Dubinett SM, Franklin WA, Riely GJ, Sos ML, Kris MG, Dias-Santagata D, Ladanyi M, Bunn PA, Pao W
(2013)
Clin Cancer Res 19: 2584-91
MeSH Terms: Adenocarcinoma, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Benzimidazoles, Cell Line, Tumor, DNA Mutational Analysis, Female, GTP Phosphohydrolases, Gene Frequency, Genetic Association Studies, Humans, Inhibitory Concentration 50, Lung Neoplasms, Male, Membrane Proteins, Middle Aged, Mutation, Missense, Protein Kinase Inhibitors, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), Pyridones, Pyrimidinones, ras ProteinsAdded September 3, 2013